The Chinese healthcare market is booming.
This leads to new opportunities for the Belgian biotech and medtech companies. The Chinese healthcare market is the second largest healthcare market. They are mainly focusing on Chinese traditional over the counter medicine. But the Chinese middle class wants better healthcare and medicine, so the industry is forcefully investing in new companies and growth of the sector.
This leads to new opportunities for Belgian companies, who are amongst the world top in healthcare and biotech. The Belgian companies can close license deals with the Chinese counterparties or they can raise money. One of the best cases is eTheRNA, one of our clients, who has set up a joint venture with Grand Pharma.
Want to read more about this topic? Click here to read the article (in Dutch).
